Science and universities minister David Willetts has revealed that the average grant funded through both late and early-stage Biomedical Catalyst awards is £1.5 million.
Willetts was responding to a written question by Liberal Democrat MP for Cambridge Julian Huppert, in parliament on 23 April.
The £180m fund, run by the Technology Strategy Board and the Medical Research Council, aims to bridge the so-called ‘valley of death’ between basic research and a marketable product.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.